Documentdetail
ID kaart

oai:arXiv.org:2408.11402

Onderwerp
Computer Science - Computer Vision...
Auteur
Lee, Minhyeok Cho, Suhwan Shin, Chajin Lee, Jungho Yang, Sunghun Lee, Sangyoun
Categorie

Computer Science

Jaar

2024

vermelding datum

18-12-2024

Trefwoorden
frame image-to-video proposed diffusion inpainting
Metriek

Beschrijving

Propagation-based video inpainting using optical flow at the pixel or feature level has recently garnered significant attention.

However, it has limitations such as the inaccuracy of optical flow prediction and the propagation of noise over time.

These issues result in non-uniform noise and time consistency problems throughout the video, which are particularly pronounced when the removed area is large and involves substantial movement.

To address these issues, we propose a novel First Frame Filling Video Diffusion Inpainting model (FFF-VDI).

We design FFF-VDI inspired by the capabilities of pre-trained image-to-video diffusion models that can transform the first frame image into a highly natural video.

To apply this to the video inpainting task, we propagate the noise latent information of future frames to fill the masked areas of the first frame's noise latent code.

Next, we fine-tune the pre-trained image-to-video diffusion model to generate the inpainted video.

The proposed model addresses the limitations of existing methods that rely on optical flow quality, producing much more natural and temporally consistent videos.

This proposed approach is the first to effectively integrate image-to-video diffusion models into video inpainting tasks.

Through various comparative experiments, we demonstrate that the proposed model can robustly handle diverse inpainting types with high quality.

;Comment: Accepted to AAAI 2025

Lee, Minhyeok,Cho, Suhwan,Shin, Chajin,Lee, Jungho,Yang, Sunghun,Lee, Sangyoun, 2024, Video Diffusion Models are Strong Video Inpainter

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw